Confronti finanziari GSK plc

Azioni

Tempo reale stimato Cboe Europe Altri mercati azionari 16:44:46 10/03/2026			Variaz. 5gg	Var. 1 gen.
2.080,00 ^GBX	+1,66%		-2,16%	+13,80%

16:40	La FDA approva l'estensione d'uso di Wellcovorin di GSK per una rara patologia neurologica	MT
15:05	La FDA approva l'estensione dell'uso delle compresse Wellcovorin di GSK	MT

Settore:

Regione:

Asse X:

Principali concorrenti

Aggiungi a una lista 0 selezionato Solo clienti o iscritti possono usare questa funzione Accedi Registrati	Fatturato (Y-1)	Margine netto (Y-1)	Margine EBIT (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
GSK PLC	43,97 Mrd	17,5%	29,95%	46,39%	9,48%	1.28x
ELI LILLY AND COMPANY	65,18 Mrd	31,67%	41,84%	106,69%	22,77%	1.2x
JOHNSON & JOHNSON	94,19 Mrd	28,46%	32,23%	31,68%	13,82%	0.84x
ABBVIE INC.	61,16 Mrd	6,91%	38,79%	64.669,09%	13,22%	2.44x
ROCHE HOLDING AG	77,58 Mrd	20,94%	35,49%	47,65%	15,43%	0.66x
NOVARTIS AG	56,67 Mrd	24,64%	38,62%	38,4%	16,33%	1.02x
ASTRAZENECA PLC	58,74 Mrd	17,41%	31,46%	31,99%	13,12%	1.2x
MERCK & CO., INC.	65,01 Mrd	28,08%	41,19%	45,52%	17,73%	1.07x
AMGEN INC.	36,75 Mrd	20,98%	44,09%	162,88%	12,98%	2.13x
GILEAD SCIENCES, INC.	29,44 Mrd	28,9%	44,81%	48,87%	17,34%	1.08x
NOVO NORDISK A/S	48,59 Mrd	33,14%	41,3%	60,7%	20,31%	0.69x
PFIZER INC.	62,58 Mrd	12,42%	35,11%	21,07%	8,73%	1.79x
BRISTOL-MYERS SQUIBB COMPANY	48,19 Mrd	14,64%	30,37%	72,08%	7,72%	1.83x
VERTEX PHARMACEUTICALS INCORPORATED	12 Mrd	32,94%	43,85%	27,07%	16,41%	-1.21x
SANOFI	51,22 Mrd	17,91%	27,85%	10,5%	6,02%	0.81x
CHUGAI PHARMACEUTICAL CO., LTD.	7,45 Mrd	33,09%	46,3%	22%	18,71%	-1.74x
TAKEDA PHARMACEUTICAL COMPANY LIMITED	30,6 Mrd	2,36%	7,48%	1,5%	1,19%	3.6x
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	3,83 Mrd	22,64%	26,77%	14,73%	13,49%	-2.98x
HALEON PLC	14,06 Mrd	12,84%	22,26%	8,8%	4,22%	2.82x
Media	45,64 Mrd	21,44%	34,72%	3.445,66%	13,11%	0,98x
Media ponderata per Capi.	59,49 Mrd	23,73%	37,32%	5.773,24%	15,68%	1,12x